Literature DB >> 18456845

Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.

José Miguel García1, Vanesa García, Cristina Peña, Gemma Domínguez, Javier Silva, Raquel Diaz, Pablo Espinosa, Maria Jesús Citores, Manuel Collado, Félix Bonilla.   

Abstract

Little is yet known about the origin and protective mechanism of free nucleic acids in plasma. We investigated the possibility of these free nucleic acids being particle associated. Plasma samples from colon cancer patients and cell culture media were subjected to various antibody incubations, ultracentrifugation, and RNA extraction protocols for total RNA, epithelial RNA, and mRNA. Flow cytometry using a Ber-EP4 antibody and confocal laser microscopy after staining with propidium iodide were also performed. mRNA levels of the LISCH7 and SDHA genes were determined in cells and in culture media. Ber-EP4 antibody and polystyrene beads coated with oligo dT sequences were employed. We observed that, after incubation, total RNA and mRNA were always detected after membrane digestion, and that epithelial RNA was detected before this procedure. In ultracentrifugation, mRNA was caught in the supernatant only if a former lysis mediated or in the pellet if there was no previous digestion. Flow cytometry determinations showed that antibody-coated microbeads keep acellular structures bearing epithelial antigens apart. Confocal laser microscopy made 1- to 2-microm-diameter particles perceptible in the vicinity of magnetic polystyrene beads. Relevant differences were observed between mRNA of cells and culture media, as there was a considerable difference in LISCH7 mRNA levels between HT29 and IMR90 cell co-cultures and their culture media. Our results support the view that extracellular RNA found in plasma from cancer patients circulates in association with or is protected in a multiparticle complex, and that an active release mechanism by tumor cells may be a possible origin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456845      PMCID: PMC2441977          DOI: 10.1261/rna.755908

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  40 in total

1.  Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.

Authors:  P Anker; M Stroun; P A Maurice
Journal:  Cancer Res       Date:  1975-09       Impact factor: 12.701

2.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

3.  Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells.

Authors:  J M Silva; R Rodriguez; J M Garcia; C Muñoz; J Silva; G Dominguez; M Provencio; P España; F Bonilla
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Telomerase RNA as a detection marker in the serum of breast cancer patients.

Authors:  X Q Chen; H Bonnefoi; M F Pelte; J Lyautey; C Lederrey; S Movarekhi; P Schaeffer; H E Mulcahy; P Meyer; M Stroun; P Anker
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

5.  Microsatellite alterations in plasma DNA of small cell lung cancer patients.

Authors:  X Q Chen; M Stroun; J L Magnenat; L P Nicod; A M Kurt; J Lyautey; C Lederrey; P Anker
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

6.  RNA-lipid complexes released from the plasma membrane of human colon carcinoma cells.

Authors:  A Rosi; L Guidoni; A M Luciani; G Mariutti; V Viti
Journal:  Cancer Lett       Date:  1988-03       Impact factor: 8.679

Review 7.  Molecular detection of micrometastases and circulating tumor cells in solid tumors.

Authors:  R A Ghossein; S Bhattacharya; J Rosai
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

8.  Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

Authors:  Enders K O Ng; Nancy B Y Tsui; Nicole Y L Lam; Rossa W K Chiu; Simon C H Yu; S C Cesar Wong; Elena S F Lo; Timothy H Rainer; Philip J Johnson; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

9.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

10.  Biochemical and NMR studies on structure and release conditions of RNA-containing vesicles shed by human colon adenocarcinoma cells.

Authors:  M Ceccarini; L Guidoni; A M Luciani; G Mariutti; A Rosi; V Viti
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

View more
  43 in total

Review 1.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

2.  Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

Authors:  S B Krintel; C Dehlendorff; M L Hetland; K Hørslev-Petersen; K K Andersen; P Junker; J Pødenphant; T Ellingsen; P Ahlquist; H M Lindegaard; A Linauskas; A Schlemmer; M Y Dam; I Hansen; H C Horn; A Jørgensen; J Raun; C G Ammitzbøll; M Østergaard; K Stengaard-Pedersen; J S Johansen
Journal:  Pharmacogenomics J       Date:  2015-05-05       Impact factor: 3.550

3.  Quantitative nanostructural and single-molecule force spectroscopy biomolecular analysis of human-saliva-derived exosomes.

Authors:  Shivani Sharma; Boyd M Gillespie; Viswanathan Palanisamy; James K Gimzewski
Journal:  Langmuir       Date:  2011-11-09       Impact factor: 3.882

Review 4.  Horizontal transfer of RNAs: exosomes as mediators of intercellular communication.

Authors:  Saraswathi Ramachandran; Viswanathan Palanisamy
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-10-19       Impact factor: 9.957

Review 5.  Extracellular RNA mediates and marks cancer progression.

Authors:  Jasmina S Redzic; Leonora Balaj; Kristan E van der Vos; Xandra O Breakefield
Journal:  Semin Cancer Biol       Date:  2014-04-28       Impact factor: 15.707

6.  The release of microparticles by Jurkat leukemia T cells treated with staurosporine and related kinase inhibitors to induce apoptosis.

Authors:  Anirudh J Ullal; David S Pisetsky
Journal:  Apoptosis       Date:  2010-05       Impact factor: 4.677

7.  EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages.

Authors:  N Mohammed; M Rodriguez; V Garcia; J M Garcia; G Dominguez; C Peña; M Herrera; I Gomez; R Diaz; B Soldevilla; A Herrera; J Silva; F Bonilla
Journal:  Oncol Lett       Date:  2011-04-28       Impact factor: 2.967

8.  Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer.

Authors:  Juan Wei; Lian-Ke Liu; Wen Gao; Cheng-Jun Zhu; Yi-Qian Liu; Ting Cheng; Yong-Qian Shu
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

9.  Nanostructural and transcriptomic analyses of human saliva derived exosomes.

Authors:  Viswanathan Palanisamy; Shivani Sharma; Amit Deshpande; Hui Zhou; James Gimzewski; David T Wong
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

10.  Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications.

Authors:  Vanesa Garcia; Jose Miguel Garcia; Javier Silva; Paloma Martin; Cristina Peña; Gemma Dominguez; Raquel Diaz; Mercedes Herrera; Constanza Maximiano; Pilar Sabin; Antonio Rueda; Miguel Angel Cruz; Jose Rodriguez; Miguel Angel Canales; Felix Bonilla; Mariano Provencio
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.